Sybilla Biotech: in-silico drug discovery

An online workshop by:

MIB Lens web workshops is proud to host the series “Deep Tech Stories”, that focuses on real business cases: companies founded on a scientific discovery or a disruptive technological innovation, aiming to achieve exponential results in new markets through the creative vision of their entrepreneurs.

The series “MIB Lens Deep Tech Stories” has been authored by Venture Factory, the number one deep-tech and technology transfer investor in Italy, and MIB partner on the EMBA IN program. The entrepreneurs will be interviewed by the Venture Factory investors, so the perspectives that will emerge form the meetings will be absolutely hands on and genuine.

Live session recording

The scientists who founded Sibylla Biotech have developed the most advanced platform for in-silico drug discovery. Sibylla has in-licensed such a platform from the research institutions and Sibylla’s multidisciplinary team is further developing the technology. The innovation is based on applying innovative algorithms derived from advanced mathematical methods of theoretical physics to transformative drug discovery protocols. These proprietary techniques have enabled to reveal with atomic resolution the folding and misfolding mechanisms of bio-medically relevant proteins, thereby unveiling an entirely new class of pharmacological targets and at the same time enabling ultra-fast assessment of druggability of complex proteins, slashing development costs and computing time by order of magnitudes.

The interviewer

Roberto Della Marina

Roberto is a Managing Partner at Venture Factory, in Milan.
He is a Venture Capitalist and an executive with wide managerial and technical skills. Effective in financing and managing top grade technology rich companies with innovative scientific and technical contamination (e.g. biomedical and micro-nanotechnology, microelectronics and "green", Biology and IT, etc). Broad experience in micro and nanotechnologies. Focus on tech transfer, bringing to the market early stage "tech-driven" companies. Deeply passionate about innovation and scientific entrepreneurship, bridging science with finance.
Specialties: Venture Capital, Tech Transfer, Robotics, Micro and Nano technologies, Microfabrication, Semiconductors, Sensors, High Energy Particle Physics, Regenerative Medicine,
C-exec skills, BusDev, Negotiation, Product and Process Innovation, BA & VC financing, Venture Scouting, Mentoring & Coaching

Other Webinars of MIB Lens series

Sybilla Biotech: in-silico drug discovery

Thursday 28 May, 6:00 pm